Patents matching “combination”

US 9114146

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Aug 25, 2015 · Expires Aug 20, 2035

US 9107887

Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer

Provectus Pharmaceuticals, Inc. · Granted Aug 18, 2015 · Expires Aug 13, 2035

US 9089531

GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

The Regents of the University of California · Granted Jul 28, 2015 · Expires Jul 23, 2035

US 9060971

Combination pharmaceutical agents as inhibitors of HCV replication

Enanta Pharmaceuticals, Inc. · Granted Jun 23, 2015 · Expires Jun 18, 2035

US 9050343

Combination of pimavanserin and risperidone for the treatment of psychosis

ACADIA Pharmaceuticals Inc. · Granted Jun 9, 2015 · Expires Jun 4, 2035

US 9012434

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Apr 21, 2015 · Expires Apr 16, 2035

US 9006222

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Apr 14, 2015 · Expires Apr 9, 2035

US 8993548

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Mar 31, 2015 · Expires Mar 26, 2035

US 8993549

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Mar 31, 2015 · Expires Mar 26, 2035

US 8986708

Combinations of gene deletions for live attenuated Shigella vaccine strains

The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Mar 24, 2015 · Expires Mar 19, 2035

US 8987238

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Mar 24, 2015 · Expires Mar 19, 2035

US 8987237

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Mar 24, 2015 · Expires Mar 19, 2035

US 8951972

FGFR1 extracellular domain combination therapies for lung cancer

Five Prime Therapeutics, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

US 8933059

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Jan 13, 2015 · Expires Jan 8, 2035

US 8927576

HCV inhibitor and therapeutic agent combinations

PTC THERAPEUTICS, INC. · Granted Jan 6, 2015 · Expires Jan 1, 2035

US 8895539

Pregnancy hormone combination for treatment of autoimmune diseases

The Regents of the University of California · Granted Nov 25, 2014 · Expires Nov 20, 2034

US 8889627

Treatment of multiple sclerosis with combination of laquinimod and fingolimod

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 18, 2014 · Expires Nov 13, 2034

US 8865728

Combinations comprising methotrexate and DHODH inhibitors

Almirall, S.A. · Granted Oct 21, 2014 · Expires Oct 16, 2034

US 8852936

Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery

Laurantis Pharma Oy · Granted Oct 7, 2014 · Expires Oct 2, 2034

US 8846648

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Sep 30, 2014 · Expires Sep 25, 2034

US 8846649

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Sep 30, 2014 · Expires Sep 25, 2034

US 8841302

HCV inhibitor and therapeutic agent combinations

PTC THERAPEUTICS, INC. · Granted Sep 23, 2014 · Expires Sep 18, 2034

US 8835405

Inhibiting arthritis via injection of synergistic combination of hyaluronic acid and vitamin C and/or vitamin E

China Medical University · Granted Sep 16, 2014 · Expires Sep 11, 2034

US 8829024

Combination steroid and glucocorticoid receptor antagonist therapy

Corcept Therapeutics Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034